NXTC - NextCure  - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

NXTC is currently covered by 1 analysts with an average price target of $7.47. This is a potential upside of $6.28 (527.73%) from yesterday's end of day stock price of $1.19.

NextCure 's activity chart (see below) currently has 48 price targets and 39 ratings on display. The stock rating distribution of NXTC is 100% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 27.04% with an average time for these price targets to be met of 53.57 days.

Highest price target for NXTC is $4, Lowest price target is $4, average price target is $7.47.

Most recent stock forecast was given by GIL BLUM from NEEDHAM on 02-Aug-2024. First documented stock forecast 03-Jun-2019.

Currently out of the existing stock ratings of NXTC, 5 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$4

$2.69 (205.34%)

$4

3 months 20 days ago
(02-Aug-2024)

0/7 (0%)

$2.4 (150.00%)

Hold

$16

2 years 18 days ago
(04-Nov-2022)

0/3 (0%)

$11.08 (225.20%)

Buy

$6

$4.69 (358.02%)

$13

2 years 19 days ago
(03-Nov-2022)

3/14 (21.43%)

$3.49 (139.04%)

56

Buy

$15

$13.69 (1045.04%)

$19

2 years 2 months 30 days ago
(23-Aug-2022)

1/4 (25%)

$10.56 (237.84%)

185

Buy

$14

$12.69 (968.70%)

$14

2 years 6 months 16 days ago
(06-May-2022)

0/3 (0%)

$10.2 (268.42%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is NXTC (NextCure ) average time for price targets to be met?

On average it took 53.57 days on average for the stock forecasts to be realized with a an average price target met ratio 27.04

Which analyst has the current highest performing score on NXTC (NextCure ) with a proven track record?

EDWARD TENTHOFF

Which analyst has the current lower performing score on NXTC (NextCure ) with a proven track record?

CHAD MESSER

Which analyst has the most public recommendations on NXTC (NextCure )?

Edward Tenthoff works at PIPER SANDLER and has 7 price targets and 3 ratings on NXTC

Which analyst is the currently most bullish on NXTC (NextCure )?

Asthika Goonewardene with highest potential upside - $13.69

Which analyst is the currently most reserved on NXTC (NextCure )?

Aydin Huseynov with lowest potential downside - -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?